Retraction of “Feprazone Prevents Free Fatty Acid (FFA)-Induced Endothelial Inflammation by Mitigating the Activation of the TLR4/MyD88/NF-κB Pathway”

The Editors retract this Article because the raw data for the work could not be provided and the results reported in Figure 7 of the original Article have been determined to be unreliable.

The original Article was published on February 9, 2021, and retracted on March 1, 2022.